Web1 Feb 2024 · February 1, 2024 The Department of Justice announced that INSYS Therapeutics, Inc. (“INSYS”) has agreed to pay $225 million to resolve allegations that it paid kickbacks and engaged in other illegal marketing tactics to … Web14 Apr 2024 · A Chapter 11 liquidating trustee has reached a $175 million settlement with four former board directors of Insys Therapeutics, manufacturer of the fentanyl spray Subsys. The settlement, filed in U ...
Opioid Maker Insys
Web16 May 2014 · The subpoena requests documents regarding Subsys, including INSYS' sales and marketing practices relating to this product." This caused the Company's shares to fall $7.73 per share, or over 17%. Web8 Jul 2024 · Insys manufactured Subsys, a powerful painkiller approximately 50 to 100 times more potent than morphine. The U.S. Food and Drug Administration (“FDA”) approved Subsys only for the management of breakthrough pain in cancer patients. josh landis fired
Congress Increases Incentives for Whistleblowers Reporting …
WebInsys Therapeutics is a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care products. We have two marketed products, Subsys and Dronabinol ... Web14 Nov 2024 · In March 2012, Insys launched its marketing campaign for Subsys, planning and funding a “speaker program” intended to increase brand awareness of the drug. Insys sales representatives were to recruit doctors and other licensed practitioners who were to be part of the speaker program and provide peer-to-peer lectures about the benefits and use … Web13 Feb 2024 · The five-minute video debuted in 2015 at an Insys national sales staff meeting, according to federal prosecutors. They played it Wednesday to a rapt US District Court jury in Boston in the... josh landry 247